Not Valid for Submission
T45.0X5 is a "header" nonspecific and non-billable code code, consider using a code with a higher level of specificity for a diagnosis of adverse effect of antiallergic and antiemetic drugs. The code is NOT valid for the year 2020 for the submission of HIPAA-covered transactions. The ICD-10-CM code T45.0X5 might also be used to specify conditions or terms like 5-ht3-receptor antagonist adverse reaction, acrivastine adverse reaction, adverse reaction to antihistamines, antazoline adverse reaction, antiallergenic drug adverse reaction, antiemetic adverse reaction, etc
| ICD-10: | T45.0X5 |
| Short Description: | Adverse effect of antiallergic and antiemetic drugs |
| Long Description: | Adverse effect of antiallergic and antiemetic drugs |
Consider the following ICD-10 codes with a higher level of specificity:
Replaced Code
This code was replaced in the 2020 ICD-10 code set with the code(s) listed below. The National Center for Health Statistics (NCHS) has published an update to the ICD-10-CM diagnosis codes which became effective October 1, 2019. This code was replaced for the FY 2020 (October 1, 2019 - September 30, 2020).
- K59.03 - Drug induced constipation
Synonyms
The following clinical terms are approximate synonyms or lay terms that might be used to identify the correct diagnosis code:
- 5-HT3-receptor antagonist adverse reaction
- Acrivastine adverse reaction
- Adverse reaction to antihistamines
- Antazoline adverse reaction
- Antiallergenic drug adverse reaction
- Antiemetic adverse reaction
- Astemizole adverse reaction
- Azatadine adverse reaction
- Azelastine adverse reaction
- Brompheniramine adverse reaction
- Cetirizine adverse reaction
- Chlorphenamine adverse reaction
- Cinnarizine adverse reaction
- Clemastine adverse reaction
- Cough suppressant adverse reaction
- Cromoglycate and related antiallergenic adverse reaction
- Cyclizine adverse reaction
- Cyproheptadine adverse reaction
- Dimenhydrinate adverse reaction
- Dimethindene adverse reaction
- Diphenhydramine adverse reaction
- Diphenylpyraline adverse reaction
- Domperidone adverse reaction
- H1 antihistamine adverse reaction
- Ketotifen adverse reaction
- Lodoxamide adverse reaction
- Loratadine adverse reaction
- Mebhydrolin adverse reaction
- Meclozine hydrochloride adverse reaction
- Mepyramine adverse reaction
- Metoclopramide adverse reaction
- Oxatomide adverse reaction
- Phenindamine adverse reaction
- Pheniramine adverse reaction
- Terfenadine adverse reaction
- Topical antihistamine adverse reaction
- Triprolidine adverse reaction
- Xanthine adverse reaction
Code Classification
Code History
- FY 2016 - New Code, effective from 10/1/2015 through 9/30/2016
(First year ICD-10-CM implemented into the HIPAA code set) - FY 2017 - No Change, effective from 10/1/2016 through 9/30/2017
- FY 2018 - No Change, effective from 10/1/2017 through 9/30/2018
- FY 2019 - No Change, effective from 10/1/2018 through 9/30/2019
- FY 2020 - No Change, effective from 10/1/2019 through 9/30/2020